Eric Sandberg is the Chief Business Officer at Inomagen Therapeutics. Eric has 30+ years of medical technology leadership experience at Guidant, Boston Scientific, Axogen and several start-up ventures, in roles that have included CEO, CBO, and CCO, and brings significant commercial experience in the cardiovascular space including cardiac rhythm management.
Eric Sandberg
Chief Business Officer
Inomagen Therapeutics